year 17, Issue 1 (January - February 2023)                   Iran J Med Microbiol 2023, 17(1): 1-6 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ramazanzadeh R, Marzban A, Khalili Fard Ardali J, Saki R, Esmaeil Lashgarian H, Shakib P. Anti-Mycobacterium tuberculosis Effects of Folk Medicinal Plants in Iran: A Mini-Systematic Review. Iran J Med Microbiol 2023; 17 (1) :1-6
URL: http://ijmm.ir/article-1-1715-en.html
1- Department of Microbiology, Ardabil University of Medical Sciences, Ardabil, Iran
2- Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
3- Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
4- Department of Microbiology, Kermanshah University of Medical Sciences, Kermanshah, Iran
5- Department of Medical Biotechnology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
6- Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran , shakib.pegah@yahoo.com
Full-Text [PDF 560 kb]   (510 Downloads)     |   Abstract (HTML)  (1750 Views)
Full-Text:   (413 Views)
Introduction


Mycobacterium tuberculosis (M. tuberculosis, Mtb) lives inside human cells and invades them, thereby causing tuberculosis (1). This disease is an ancient illness that is spread in communities by droplets. Tuberculosis has been controlled after discovering antituberculosis drugs such as ethambutol, isoniazid, streptomycin, and rifampin (2, 3). However, with the evolution of drug resistance via diverse mechanisms, such as the development of drug-inactivating enzymes, changes in drug target sites, and the emergence of isolates with multiple resistance, there has been an upsurge in new cases reported (4, 5). Thus, healthcare systems worldwide confront many challenges in managing and treating these infections. According to statistics from 2010, 650000 instances of multidrug-resistant TB (MDR) were documented as attributable to M. tuberculosis (6).
Many plants are used in traditional medicine worldwide to treat bacterial infections (7). Recent research has aimed to identify herbal medicines that are simpler to obtain, have fewer adverse effects, and are less expensive to be used in conjunction with synthetic pharmaceuticals. Because of their secondary components, herbal medicines have proved to be an effective source of therapy for controlling and treating bacterial infections (8, 9). In Iran, the use of traditional medicinal remedies for the treatment of infections has been widespread since ancient times. Our objective in this review is to summarize the research being done on Iranian medicinal plants as a way to tackle TB infection.


 

Materials and Methods

According to the Preferred Systematic Review Reporting (PRISMA) guidelines, relevant data were retrieved from papers in October 2021 by two authors. This systematic review was conducted by evaluating papers published in both English and Persian. Several databases, including Science Direct, Scopus, PubMed, Ovid, Cochrane, Scientific Information Database (SID), Iran Medex, Iran Doc, and Magiran, were searched using relevant keywords for papers published between 2000 and 2020. The following keywords were used to describe the study: medicinal plants, M. tuberculosis infection, tuberculosis, MTB, essential oils, and extracts. Two authors read the literature and then combined their findings in consultation and collaboration.

Criteria Consideration

Inclusion Criteria

The following criteria were used to select the published articles for inclusion in the discussion: studies describing the effect of Iranian native medicinal plants on M. tuberculosis in their entirety, including the full text of the studies written in Persian and English, studies published in reputable journals, studies with clear information, and those that only demonstrated the effect of Iranian native medicinal plants on M. tuberculosis.

Exclusion Criteria

Exclusion criteria included studies with no available full text, case report studies, case series, systematic reviews, abstracts of papers presented at seminars and conferences, and studies with insufficient evidence for analysis (Figure 1).

 

Figure 1. PRISMA graph of data retrieved from various databases based on inclusion and exclusion criteria 
Figure 1. PRISMA graph of data retrieved from various databases based on inclusion and exclusion criteria

 

Data Extraction

The required information was extracted from articles, including plant name and its family, concentration, positive control dose, and treatment period by two researchers and then merged with consultation as well as consensus.
 

 

Results

Selected studies

Data details, including their herbal family, used organs of the plants, and place of occurrence, are reported in Table 1. According to these results, 13 medicinal plants were detected with anti-M. tuberculosis effects in Iran include Peganum harmala, Humulus lupulus, Capparis spinosa, Thymus vulgaris, Pulicaria gnaphalodes, Perovskia abrotanoides, Peganum harmala, Punica granatum, Digitalis sp., Citrus lemon, Rosa canina, Berberis vulgaris, Aloe vera, mint, Hypericum perforatum, Humulus lupulus, Trachyspermum copticum, Pelargonium graveolens, and Levisticum officinale Dracocephalum kotschyi.

 
Table1. List of medicinal plants affecting Mycobacterium tuberculosis

Ref MIC Zone(mm) Native Organ Herbal family Scientific name
(10) - 18.7±3.5 North of Iran Root and seed Nitrariaceae Peganum harmala
(11) 4 and 8 mg/mL - Iran stems, leaves and
roots
Cannabaceae Humulus lupulus
(12) 25 mg/mL - Iran fruit Caper bush Capparis spinosa
(13) 0.5-40 μg/mL - Tehran, Iran oil Lamiaceae Thymus vulgaris
(14) 640 μg/mL - Iran oil sunflower Pulicaria gnaphalodes
(14) 640 μg/mL - Iran oil Salvia Perovskia abrotanoides
(15) 50 mg/mL 18.7 North of Iran seed Nitrariaceae Peganum harmala
(15) 25 mg/mL 18.8 North of Iran peel Lythraceae Punica granatum
(15) 100mg/mL 12.5 North of Iran leaf Plantaginaceae Digitalis sp.
(15) 200mg/mL 12.5 North of Iran fruit Rutaceae Citrus lemon
(15) 0 0 North of Iran fruit Rosaceae Rosa canina
(15) 0 0 North of Iran fruit Berberidaceae Berberis vulgaris
(16) - 60 Iran leaves, Asphodelaceae Aloe vera
(16) - 0 Iran leaves Lamiaceae mint
(16) - 41 Iran leaves Hypericaceae Hypericum perforatum
(17) 15.7 μg/mL(Aqueous) 31.2 μg/mL(ethanol) - Iran Petals Cannabaceae Humulus lupulus
(18) 19.5 μg/mL - Iran oils Apiaceae Trachyspermum copticum
(18) 78 μg/mL - Iran oils Pelargonium graveolens Pelargonium graveolens
(19) 32 and 64 μg/mL - Iran roots Apiaceae Levisticum officinale
(20) 640 μg/mL - Iran leaves Lamiaceae Dracocephalum kotschyi


Peganum harmala: Based on the results of the antimicrobial and antioxidant properties of Davoodi et al. and Jahanpour et al. studies, it was found that Peganum harmala leaves and seeds have potential as complementary medicine for the treatment of M. tuberculosis, even against resistant strains (10, 15).
Humulus lupulus: Serkani et al. described the antimicrobial effect of stems, leaves, and roots of  Humulus lupulus on rifampin-sensitive and resistant isolates of M. tuberculosis in different concentrations of hop ethanol extract (4 and 8 mg/mL) (11). In Rafiee et al. study, the MIC levels of aqueous and ethanol extracts of Humulus lupulus were reported as 7.8 μg/mL and 15.7 μg/mL, respectively. The amount of MBC was 15.7 μg/mL and 31.2 μg/mL, respectively. Therefore, the results indicated strong antimicrobial activity of aqueous and ethanolic extracts of Humulus lupulus against M. tuberculosis (17).
Capparis spinosa: In the study of Ehsanifar et al., the antimycobacterial effect of the methanolic extract of the Capparis spinosa at a concentration of 25 mg/mL was reported in clinical isolates sensitive to rifampin (12).
Thymus vulgaris: Pourazar Dizaji reported the MIC values of isoniazid, ethambutol, streptomycin, and cycloserine less than 10 μg/mL and MIC values for rifampicin and kanamycin 40 μg/mL. In addition, they reported MIC of Thymus vulgaris essential oil between 0.5 and 40 µg/mL (P<0.05). Therefore, they showed that thyme essential oil has antibacterial activity against M. tuberculosis (13).
Pulicaria gnaphalodes: The results of Hozoorbakhsh et al. showed that the essential oil extract of P. gnaphalodes has strong inhibitory effects on MTB up to about (70.9%) (14). In Jahanpour et al. study, the ethanol extract of Punica granatum bark showed an average inhibition zone of 18.8 mm at a concentration of 200 mg/mL against M. tuberculosis isolates, while the average inhibition zone around isoniazid and rifampin was 19.2 and 18.8 mm. The results indicated a potential activity against M. tuberculosis isolates (15).
Perovskia abrotanoides: The results of Hozoorbakhsh et al. showed that the essential oil extract of Perovskia abrotanoides has strong inhibitory effects on M. tuberculosis up to about (86%) (14).
Digitalis sp: In Jahanpour et al. study, the Ethanol extract of Digitalis sp. has a mild antimycobacterial effect at concentrations of 200 and 100 mg/mL showed that in this study, isoniazid and rifampin antibiotics inhibited non-MDR M. tuberculosis isolates, so the results indicate the potential efficacy of Digitalis sp ethanolic extract against M. tuberculosis (15).
Citrus lemon: The results of the Jahanpour et al. study showed that the ethanolic extract of Citrus lemon could prevent the growth of non-MDR M. tuberculosis in concentrations of 200 and 25 mg/mL (15).
Rosa canina and  Berberis vulgaris: In investigating the antimicrobial activity of Berberis vulgaris and Rosa canina fruit extracts, it was found that the extracts of these fruits do not have antimicrobial activity against M. tuberculosis isolates (15).
Aloe vera: In investigating the antimicrobial properties of A. vera against M. tuberculosis isolates by disc diffusion method, the inhibition zones of A. vera extract of 60 mm were reported. Also, based on the results, 50% of the cells were killed in 24 hours and 20% in 10 minutes when exposed to Aqueous A. vera extract (16).
Mint: Antimicrobial effects of mint on M. tuberculosis isolates showed that the zone of inhibition of mint extract was 0 mm, also, the time to kill 95% of cells in contact with the aqueous extract of mint was reported for a week (16).
Hypericum perforatum: In a study, the inhibition zones of the aqueous extract of Hypericum perforatum against M. tuberculosis were reported 41 mm. 50% of the cells were killed in 24 hours and 20% in 10 minutes when exposed to Aqueous Hypericum perforatum (16).
Trachyspermum copticum: In Kardan et al., study the MIC values for Trachyspermum copticum against M. tuberculosis isolates were from 19.5 µg/mL to 78 µg/mL (18). Therefore, the antimicrobial properties of Trachyspermum copticum against M. tuberculosis were reported.
Pelargonium graveolens: In Kardan et al. study, the MIC values for Pelargonium graveolens against M. tuberculosis isolates was 78 µg/mL (18). As a result, this essential oil was effective against M. tuberculosis isolates.
Levisticum officinale: Monsefesfahani et al.’s study of phytochemical isolation of Levisticum officinale extract and investigation of their antimicrobial properties showed that Falcarindiol and oxypeucedanin have moderate antimicrobial activity against MDR M. tuberculosis with MIC values = 32 and 64 μg/mL (19).
Dracocephalum kotschyi: In the study, it was found that the methanolic extract of Dracocephalum kotschyi at a concentration of 640 μg/mL was significantly effective against M. tuberculosis sensitive and resistant to isoniazid (20).

 
 

Discussion

The emergence of multidrug-resistant M. tuberculosis (MDR) and extended drug-resistant M. tuberculosis (XDR) are the most important challenges in TB control. The mechanisms of drug resistance are attributed to the inappropriate use of anti-TB drugs. Thus, the long-standing prevalence of TB in various communities and the lack of novel drugs that may be used to treat it has exacerbated concerns. In this regard, scientists worldwide attempt to create new treatments that might eliminate TB. According to the findings, herbal medicines are sought for development as alternative pharmaceuticals to manage TB cases since they are less costly and have fewer adverse effects than chemical drugs. Peganum harmala, Humulus lupulus, Capparis spinosa, Thymus vulgaris, Pulicaria gnaphalodes, Perovskia abrotanoides, Peganum harmala, Punica granatum, Digitalis sp., Citrus lemon, Rosa canina, Berberis vulgaris, Aloe vera, Mentha spp., Hypericum perforatum, Humulus lupulus, Trachyspermum copticum, Pelargonium graveolens, and Levisticum officinale Dracocephalum kotschyi have been reported as Iranian native plants affecting tuberculosis infection. Humulus lupulus was effective against susceptible and resistant Mycobacterium isolates, with Humulus lupulus also exhibiting antibacterial efficacy against rifampin-resistant Mycobacterium isolates at a MIC value of 8 mg/mL (11). Also, Thymus vulgaris showed effects on M. tuberculosis. It was observed that T. Vulgaris essential oil had a substantially lower MIC value than typical medications, including ethambutol, isoniazid, streptomycin, and cycloserine, which are often used for the treatment of infections (13). Another study evaluated the inhibitory effect of alcoholic extracts of Berberis vulgaris, Rosa canina, Peganum harmala, Punica granatum, Digitalis sp, and Citrus lemon on Mycobacterium isolates. The findings indicated that extracts of Peganum harmala, Punica granatum, Digitalis sp, and Citrus lemon exhibited inhibitory effects against non-MDR bacteria at various doses, with Punica granatum showing the maximum inhibition zone (19.5 mm) against isoniazid and rifampin-resistant isolates. On the other hand, neither Berberis vulgaris nor Rosa canina inhibited M. tuberculosis isolates (18).
These findings revealed that various natural Iranian plants might effectively inhibit Mycobacterium isolates. However, in vitro and in vivo experiments are required to obtain further insight into antimycobacterial mechanisms.


 

Conclusion

There are promising results regarding the antibacterial efficacy of Iranian medicinal plants that have been studied recently. However, further investigation into their metabolites will be required to corroborate these claims. Additionally, a combination treatment, including using these herbs in conjunction with one another or with standard antibiotics, may effectively reduce antibiotic resistance in M. tuberculosis.

 

Acknowledgment

The authors appreciate the Vice Chancellor for Research and Technology of Lorestan University of Medical Sciences and state that this review article did not receive any financial support.
 
 

Funding

None.

 

Author s Contributions

Conceptualization, Shakib. P; methodology, Marzban. A & Lashgarian. H.E; investigation, Saki. R; writing—original draft preparation, Ramazanzadeh. R; writing—review and editing, Khalili Fard Ardali. J; supervision, Shakib. P.

 

Conflicts of Interest

The authors declared no conflicts of interest.


 

Type of Study: Review Article | Subject: Medical Bacteriology
Received: 2022/04/5 | Accepted: 2022/08/3 | ePublished: 2023/01/20

References
1. Ramazanzadeh R, Shakib P, Rouhi S. Prevalence of Mycobacterium tuberculosis T family in different continents (2000-2012): A systematic review and meta-analysis. Int J Mycobacteriol. 2015;4:120. [DOI:10.1016/j.ijmyco.2014.11.060] [DOI:10.1016/j.ijmyco.2014.11.025] [DOI:10.1016/10.1016/j.ijmyco.2014.11.023]
2. Basso LA, Zheng R, Musser JM, Jacobs Jr WR, Blanchard JS. Mechanisms of Isoniazid Resistance in Mycobacterium tuberculosis: Enzymatic Characterization of Enoyl Reductase Mutants Identified in Isoniazid-Resistant Clinical Isolates. J Infect Dis. 1998;178(3):769-75. [DOI:10.1086/515362] [PMID]
3. Ramazanzadeh R, Shakib P, Rouhi S, Mohammadi B, Mohajeri P, Borji S. Molecular epidemiology of Mycobacterium tuberculosis isolates in Iran using spoligotyping. New Microbes New Infect. 2020;38:100767. [DOI:10.1016/j.nmni.2020.100767] [PMID] [PMCID]
4. Rouhi S, Rooshani D, Shakib P, Ahangar Kani F, Ramazanzadeh R. A 10-year survey on prevalence and occurrence rate of multidrug resistant Mycobacterium tuberculosis in Latin American and Mediterranean Families: A Systematic review and meta-analysis. Iran J Basic Med Sci. 2018;5(1):51-61. [DOI:10.29252/jbrms.5.1.51]
5. Vicente D, Basterretxea M, Dela Caba I, Sancho R, López-Olaizola M, Cilla G. Low antimicrobial resistance rates of Mycobacterium tuberculosis complex between 2000 and 2015 in Gipuzkoa, northern Spain. Enferm Infecc Microbiol Clin. 2019;37(9):574-9. [DOI:10.1016/j.eimc.2019.01.016] [PMID]
6. Chiang CY, Centis R, Migliori GB. Drug-resistant tuberculosis: Past, present, future. Respirology. 2010;15(3):413-32. [DOI:10.1111/j.1440-1843.2010.01738.x] [PMID]
7. Martin K, Ernst E. Herbal medicines for treatment of bacterial infections: a review of controlled clinical trials. J Antimicrob Chemother. 2003;51(2):241-6. [DOI:10.1093/jac/dkg087] [PMID]
8. Melo JOD, Saltoratto ALF, Rizo WF, Jesus HCRD, Arrigoni-Blank MDF, Alves PB, et al. Cytotoxic effects of essential oils from three Lippia gracilis Schauer genotypes on HeLa, B16, and MCF-7 cells and normal human fibroblasts. 2014;13(2):2691-7. [DOI:10.4238/2014.April.8.12] [PMID]
9. Vanajothi R, Sudha A, Manikandan R, Rameshthangam P, Srinivasan P. Luffa acutangula and Lippia nodiflora leaf extract induces growth inhibitory effect through induction of apoptosis on human lung cancer cell line. Biomed Prev Nutr. 2012;2(4):287-93. [DOI:10.1016/j.bionut.2012.03.002]
10. Davoodi H, Ghaemi E, Mazandarani M, Shakeri F. Anti-mycobacterial and anti-inflammatory activity of Peganum harmala. J Chem Pharm Res. 2015;7(4):1611-6.
11. Serkani JE, Isfahani BN, Safaei HG, Kermanshahi RK, Asghari G. Evaluation of the effect of Humulus lupulus alcoholic extract on rifampin-sensitive and resistant isolates of Mycobacterium tuberculosis. Res Pharm Sci. 2012;7(4):235-42.
12. Ehsanifar A, Kazemipoor N, Fouladi B. Anti-mycobacterial activity of capparis spinosa l. Extract against clinical isolates of Mycobacterium tuberculosis. Asian Asian J Pharm Clin Res. 2017;10(8):181-5. [DOI:10.22159/ajpcr.2017.v10i8.17629]
13. Pourazar Dizaji Sh, Soleimani N, Afrugh P, Saedi S. In vitro Antibacterial Activity of Thymus vulgaris Essential Oil against Mycobacterium tuberculosis. Infect Epidemiol Microbiol. 2018;4(2):47-51.
14. Hozoorbakhsh F, Esfahani BN, Moghim S, Asghari G. Evaluation of the effect of Pulicaria gnaphalodes and Perovskia abrotanoides essential oil extracts against Mycobacterium tuberculosis strains. Adv Biomed Res. 2016;5:79. [DOI:10.4103/2277-9175.180991] [PMID] [PMCID]
15. Jahanpour S, Ghazisaidi K, Davoodi H, Mazandarani M, Samet M, Jahanpour N, et al. Antimicrobial Effects of Folk Medicinal Plants From the North of Iran Against Mycobacterium tuberculosis. Arch Pediatr Infect Dis. 2015;3(1 TB):e18098. [DOI:10.5812/pedinfect.18098]
16. Arjomandzadegan M, Emami N, Habibi G, Farazi A, Kahbazi M, Sarmadian H, et al. Antimycobacterial activity assessment of three ethnobotanical plants against Mycobacterium Tuberculosis: An In Vitro Study. Int J Mycobacteriol. 2016;5(5):108-9. [DOI:10.1016/j.ijmyco.2016.10.025] [PMID]
17. Rafiee B, Sadeghi D, Ghani S, Mosavari N, Hosseini SA. Antibacterial Effect of Aqueous and Ethanolic Extracts of Humulus Lupulus on Mycobacterium tuberculosis. Qom Univ Med Sci J. 2017;11(8):22-8.
18. Kardan Yamchi J, Mahboubi M, Kazemian H, Hamzelou G, Feizabadi MM. The chemical composition and antimycobacterial activities of Trachyspermum copticum and Pelargonium graveolens essential oils. Recent Pat Antiinfect Drug Discov. 2020;15(1):68-74. [DOI:10.2174/1574891X14666191028113321] [DOI:10.2174/22124071MTAxfOTUvx] [PMID]
19. Esfahani HM, Farimani MM, Ebrahimi SN, Jung JH, Aliahmadi A, Abbas-Mohammadi M, et al. Antibacterial components of Levisticum officinale koch against multidrug-resistant Mycobacterium tuberculosis. Pharmaceutical Sciences. 2020;26(4):441-7. [DOI:10.34172/PS.2020.38]
20. Asghari G, Nasr Esfahani B, Paydar P. Evaluating the effect of Dracocephalum kotschyi methanol extract on Mycobacterium tuberculosis. Res j pharmacogn. 2015;2(3):31-6.

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc